TY - JOUR
AU - Park, J. W.
AU - Kim, M.
PY - 2016
DA - 2016//
TI - Replicating viruses for gynecologic cancer therapy
JO - Eur J Gynaecol Oncol
VL - 37
ID - Park2016
ER -
TY - JOUR
AU - Hartkopf, A. D.
AU - Fehm, T.
AU - Wallwiener, D.
AU - Lauer, U.
PY - 2011
DA - 2011//
TI - Oncolytic virotherapy of gynecologic malignancies
JO - Gynecol Oncol
VL - 120
UR - https://doi.org/10.1016/j.ygyno.2010.10.031
DO - 10.1016/j.ygyno.2010.10.031
ID - Hartkopf2011
ER -
TY - JOUR
AU - Chan, W. M.
AU - Rahman, M. M.
AU - McFadden, G.
PY - 2013
DA - 2013//
TI - Oncolytic myxoma virus: the path to clinic
JO - Vaccine
VL - 31
UR - https://doi.org/10.1016/j.vaccine.2013.05.056
DO - 10.1016/j.vaccine.2013.05.056
ID - Chan2013
ER -
TY - JOUR
AU - Heiber, J. F.
AU - Xu, X. X.
AU - Barber, G. N.
PY - 2011
DA - 2011//
TI - Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer
JO - Chin J Cancer
VL - 30
UR - https://doi.org/10.5732/cjc.011.10205
DO - 10.5732/cjc.011.10205
ID - Heiber2011
ER -
TY - JOUR
AU - Matthews, K. S.
AU - Alvarez, R. D.
AU - Curiel, D. T.
PY - 2009
DA - 2009//
TI - Advancements in adenoviral based virotherapy for ovarian cancer
JO - Adv Drug Deliv Rev
VL - 61
UR - https://doi.org/10.1016/j.addr.2009.04.012
DO - 10.1016/j.addr.2009.04.012
ID - Matthews2009
ER -
TY - JOUR
AU - Benencia, F.
AU - Coukos, G.
PY - 2008
DA - 2008//
TI - Biological therapy with oncolytic herpesvirus
JO - Adv Exp Med Biol
VL - 622
UR - https://doi.org/10.1007/978-0-387-68969-2_18
DO - 10.1007/978-0-387-68969-2_18
ID - Benencia2008
ER -
TY - JOUR
AU - Bauerschmitz, G. J.
AU - Guse, K.
AU - Kanerva, A.
AU - Menzel, A.
AU - Herrmann, I.
AU - Desmond, R. A.
PY - 2006
DA - 2006//
TI - Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells
JO - Mol Ther
VL - 14
UR - https://doi.org/10.1016/j.ymthe.2006.01.010
DO - 10.1016/j.ymthe.2006.01.010
ID - Bauerschmitz2006
ER -
TY - JOUR
AU - Stoff-Khalili, M. A.
AU - Dall, P.
AU - Curiel, D. T.
PY - 2004
DA - 2004//
TI - From gene therapy to virotherapy for ovarian cancer
JO - Minerva Ginecol
VL - 56
ID - Stoff-Khalili2004
ER -
TY - JOUR
AU - Kanerva, A.
AU - Zinn, K. R.
AU - Chaudhuri, T. R.
AU - Lam, J. T.
AU - Suzuki, K.
AU - Uil, T. G.
PY - 2003
DA - 2003//
TI - Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
JO - Mol Ther
VL - 8
UR - https://doi.org/10.1016/S1525-0016(03)00200-4
DO - 10.1016/S1525-0016(03)00200-4
ID - Kanerva2003
ER -
TY - JOUR
AU - Rocconi, R. P.
AU - Numnum, T. M.
AU - Stoff-Khalili, M.
AU - Makhija, S.
AU - Alvarez, R. D.
AU - Curiel, D. T.
PY - 2005
DA - 2005//
TI - Targeted gene therapy for ovarian cancer
JO - Curr Gene Ther
VL - 5
UR - https://doi.org/10.2174/156652305774964668
DO - 10.2174/156652305774964668
ID - Rocconi2005
ER -
TY - JOUR
AU - Hakkarainen, T.
AU - Hemminki, A.
AU - Pereboev, A. V.
AU - Barker, S. D.
AU - Asiedu, C. K.
AU - Strong, T. V.
PY - 2003
DA - 2003//
TI - CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses
JO - Clin Cancer Res
VL - 9
ID - Hakkarainen2003
ER -
TY - JOUR
AU - Page, J. G.
AU - Tian, B.
AU - Schweikart, K.
AU - Tomaszewski, J.
AU - Harris, R.
AU - Broadt, T.
PY - 2007
DA - 2007//
TI - Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
JO - Am J Obstet Gynecol
VL - 196
UR - https://doi.org/10.1016/j.ajog.2006.12.016
DO - 10.1016/j.ajog.2006.12.016
ID - Page2007
ER -
TY - JOUR
AU - Kelly, F. J.
AU - Miller, C. R.
AU - Buchsbaum, D. J.
AU - Gomez-Navarro, J.
AU - Barnes, M. N.
AU - Alvarez, R. D.
PY - 2000
DA - 2000//
TI - Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro
JO - Clin Cancer Res
VL - 6
ID - Kelly2000
ER -
TY - JOUR
AU - Dmitriev, I.
AU - Krasnykh, V.
AU - Miller, C. R.
AU - Wang, M.
AU - Kashentseva, E.
AU - Mikheeva, G.
PY - 1998
DA - 1998//
TI - An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
JO - J Virol
VL - 72
ID - Dmitriev1998
ER -
TY - JOUR
AU - Suzuki, K.
AU - Fueyo, J.
AU - Krasnykh, V.
AU - Reynolds, P. N.
AU - Curiel, D. T.
AU - Alemany, R.
PY - 2001
DA - 2001//
TI - A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency
JO - Clin Cancer Res
VL - 7
ID - Suzuki2001
ER -
TY - JOUR
AU - Kimball, K. J.
AU - Preuss, M. A.
AU - Barnes, M. N.
AU - Wang, M.
AU - Siegal, G. P.
AU - Wan, W.
PY - 2010
DA - 2010//
TI - A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases
JO - Clin Cancer Res
VL - 16
UR - https://doi.org/10.1158/1078-0432.CCR-10-0791
DO - 10.1158/1078-0432.CCR-10-0791
ID - Kimball2010
ER -
TY - JOUR
AU - Woller, N.
AU - Gurlevik, E.
AU - Ureche, C. I.
AU - Schumacher, A.
AU - Kuhnel, F.
PY - 2014
DA - 2014//
TI - Oncolytic viruses as anticancer vaccines
JO - Front Oncol
VL - 4
UR - https://doi.org/10.3389/fonc.2014.00188
DO - 10.3389/fonc.2014.00188
ID - Woller2014
ER -
TY - JOUR
AU - Lichty, B. D.
AU - Breitbach, C. J.
AU - Stojdl, D. F.
AU - Bell, J. C.
PY - 2014
DA - 2014//
TI - Going viral with cancer immunotherapy
JO - Nat Rev Cancer
VL - 14
UR - https://doi.org/10.1038/nrc3770
DO - 10.1038/nrc3770
ID - Lichty2014
ER -
TY - JOUR
AU - Elsedawy, N. B.
AU - Russell, S. J.
PY - 2013
DA - 2013//
TI - Oncolytic vaccines
JO - Expert Rev Vaccines
VL - 12
UR - https://doi.org/10.1586/14760584.2013.836912
DO - 10.1586/14760584.2013.836912
ID - Elsedawy2013
ER -
TY - STD
TI - Swift SL, Stojdl DF. Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy. Viruses. 2016;8(2):45.
ID - ref20
ER -
TY - JOUR
AU - Forbes, N. E.
AU - Krishnan, R.
AU - Diallo, J. S.
PY - 2014
DA - 2014//
TI - Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses
JO - Front Oncol
VL - 4
UR - https://doi.org/10.3389/fonc.2014.00191
DO - 10.3389/fonc.2014.00191
ID - Forbes2014
ER -
TY - JOUR
AU - Li, X.
AU - Mao, Q.
AU - Wang, D.
AU - Zhang, W.
AU - Xia, H.
PY - 2012
DA - 2012//
TI - A fiber chimeric CRAd vector Ad5/11-D24 double-armed with TRAIL and arresten for enhanced glioblastoma therapy
JO - Hum Gene Ther
VL - 23
UR - https://doi.org/10.1089/hum.2011.130
DO - 10.1089/hum.2011.130
ID - Li2012
ER -
TY - JOUR
AU - Yang, S. W.
AU - Chanda, D.
AU - Cody, J. J.
AU - Rivera, A. A.
AU - Waehler, R.
AU - Siegal, G. P.
PY - 2011
DA - 2011//
TI - Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer
JO - PLoS One
VL - 6
UR - https://doi.org/10.1371/journal.pone.0025131
DO - 10.1371/journal.pone.0025131
ID - Yang2011
ER -
TY - JOUR
AU - Cody, J. J.
AU - Douglas, J. T.
PY - 2009
DA - 2009//
TI - Armed replicating adenoviruses for cancer virotherapy
JO - Cancer Gene Ther
VL - 16
UR - https://doi.org/10.1038/cgt.2009.3
DO - 10.1038/cgt.2009.3
ID - Cody2009
ER -
TY - JOUR
AU - Young, A. -. M.
AU - Archibald, K. M.
AU - Tookman, L. A.
AU - Pool, A.
AU - Dudek, K.
AU - Jones, C.
PY - 2012
DA - 2012//
TI - Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo
JO - Mol Ther
VL - 20
UR - https://doi.org/10.1038/mt.2012.116
DO - 10.1038/mt.2012.116
ID - Young2012
ER -
TY - JOUR
AU - Wang, H.
AU - Wei, F.
AU - Zhang, J.
AU - Wang, F.
AU - Li, H.
AU - Chen, X.
PY - 2012
DA - 2012//
TI - A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy
JO - Tumor Biol
VL - 33
UR - https://doi.org/10.1007/s13277-012-0374-7
DO - 10.1007/s13277-012-0374-7
ID - Wang2012
ER -
TY - JOUR
AU - Kang, S.
AU - Kim, J. -. H.
AU - Kim, S. Y.
AU - Kang, D.
AU - Je, S.
AU - Song, J. J.
PY - 2014
DA - 2014//
TI - Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus
JO - Biochem Biophys Res Commun
VL - 453
UR - https://doi.org/10.1016/j.bbrc.2014.09.107
DO - 10.1016/j.bbrc.2014.09.107
ID - Kang2014
ER -
TY - JOUR
AU - Gibson, H.
AU - Munns, S.
AU - Freytag, S.
AU - Barton, K.
AU - Veenstra, J.
AU - Bettahi, I.
PY - 2015
DA - 2015//
TI - Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors
JO - Oncoimmunology
VL - 4
UR - https://doi.org/10.4161/2162402X.2014.984523
DO - 10.4161/2162402X.2014.984523
ID - Gibson2015
ER -
TY - JOUR
AU - Cheng, P. -. H.
AU - Rao, X. -. M.
AU - Wechman, S. L.
AU - Li, X. -. F.
AU - McMasters, K. M.
AU - Zhou, H. S.
PY - 2015
DA - 2015//
TI - Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice
JO - BMC Cancer
VL - 15
UR - https://doi.org/10.1186/s12885-015-1731-x
DO - 10.1186/s12885-015-1731-x
ID - Cheng2015
ER -
TY - JOUR
AU - Jiang, H.
AU - Clise-Dwyer, K.
AU - Ruisaard, K. E.
AU - Fan, X.
AU - Tian, W.
AU - Gumin, J.
PY - 2014
DA - 2014//
TI - Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model
JO - PLoS One
VL - 9
UR - https://doi.org/10.1371/journal.pone.0097407
DO - 10.1371/journal.pone.0097407
ID - Jiang2014
ER -
TY - JOUR
AU - Zhang, L.
AU - Hedjran, F.
AU - Larson, C.
AU - Perez, G.
AU - Reid, T.
PY - 2015
DA - 2015//
TI - A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
JO - Cancer Gene Ther
VL - 22
UR - https://doi.org/10.1038/cgt.2014.64
DO - 10.1038/cgt.2014.64
ID - Zhang2015
ER -
TY - JOUR
AU - Al-Zaher, A. A.
AU - Moreno, R.
AU - Fajardo, C. A.
AU - Arias-Badia, M.
AU - Farrera, M.
AU - Sostoa, J.
PY - 2018
DA - 2018//
TI - Evidence of anti-tumoral efficacy in an immune competent setting with an iRGD-modified hyaluronidase-armed oncolytic adenovirus
JO - Molecular Therapy-Oncolytics
VL - 8
UR - https://doi.org/10.1016/j.omto.2018.01.003
DO - 10.1016/j.omto.2018.01.003
ID - Al-Zaher2018
ER -
TY - JOUR
AU - Mo, L.
AU - Bachelder, R. E.
AU - Kennedy, M.
AU - Chen, P. H.
AU - Chi, J. T.
AU - Berchuck, A.
PY - 2015
DA - 2015//
TI - Syngeneic murine ovarian Cancer model reveals that ascites enriches for ovarian Cancer stem-like cells expressing membrane GRP78
JO - Mol Cancer Ther
VL - 14
UR - https://doi.org/10.1158/1535-7163.MCT-14-0579
DO - 10.1158/1535-7163.MCT-14-0579
ID - Mo2015
ER -
TY - JOUR
AU - Walton, J.
AU - Blagih, J.
AU - Ennis, D.
AU - Leung, E.
AU - Dowson, S.
AU - Farquharson, M.
PY - 2016
DA - 2016//
TI - CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma
JO - Cancer Res
VL - 76
UR - https://doi.org/10.1158/0008-5472.CAN-16-1272
DO - 10.1158/0008-5472.CAN-16-1272
ID - Walton2016
ER -
TY - JOUR
AU - Fallaux, F. J.
AU - Kranenburg, O.
AU - Cramer, S. J.
AU - Houweling, A.
AU - Ormondt, H.
AU - Hoeben, R. C.
PY - 1996
DA - 1996//
TI - Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors
JO - Hum Gene Ther
VL - 7
UR - https://doi.org/10.1089/hum.1996.7.2-215
DO - 10.1089/hum.1996.7.2-215
ID - Fallaux1996
ER -
TY - JOUR
AU - Egan, C.
AU - Jelsma, T. N.
AU - Howe, J. A.
AU - Bayley, S. T.
AU - Ferguson, B.
AU - Branton, P. E.
PY - 1988
DA - 1988//
TI - Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5
JO - Mol Cell Biol
VL - 8
UR - https://doi.org/10.1128/MCB.8.9.3955
DO - 10.1128/MCB.8.9.3955
ID - Egan1988
ER -
TY - JOUR
AU - Fueyo, J.
AU - Gomez-Manzano, C.
AU - Alemany, R.
AU - Lee, P. S.
AU - McDonnell, T. J.
AU - Mitlianga, P.
PY - 2000
DA - 2000//
TI - A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
JO - Oncogene
VL - 19
UR - https://doi.org/10.1038/sj.onc.1203251
DO - 10.1038/sj.onc.1203251
ID - Fueyo2000
ER -
TY - JOUR
AU - Heise, C.
AU - Hermiston, T.
AU - Johnson, L.
AU - Brooks, G.
AU - Sampson-Johannes, A.
AU - Williams, A.
PY - 2000
DA - 2000//
TI - An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
JO - Nat Med
VL - 6
UR - https://doi.org/10.1038/80474
DO - 10.1038/80474
ID - Heise2000
ER -
TY - JOUR
AU - Suzuki, K.
AU - Alemany, R.
AU - Yamamoto, M.
AU - Curiel, D. T.
PY - 2002
DA - 2002//
TI - The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses
JO - Clin Cancer Res
VL - 8
ID - Suzuki2002
ER -
TY - JOUR
AU - Kim, K. H.
AU - Dmitriev, I. P.
AU - Saddekni, S.
AU - Kashentseva, E. A.
AU - Harris, R. D.
AU - Aurigemma, R.
PY - 2013
DA - 2013//
TI - A phase I clinical trial of Ad5/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
JO - Gynecol Oncol
VL - 130
UR - https://doi.org/10.1016/j.ygyno.2013.06.003
DO - 10.1016/j.ygyno.2013.06.003
ID - Kim2013
ER -
TY - JOUR
AU - Fisher, P. B.
AU - Sarkar, D.
AU - Lebedeva, I. V.
AU - Emdad, L.
AU - Gupta, P.
AU - Sauane, M.
PY - 2007
DA - 2007//
TI - Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma
JO - Toxicol Appl Pharmacol
VL - 224
UR - https://doi.org/10.1016/j.taap.2006.11.021
DO - 10.1016/j.taap.2006.11.021
ID - Fisher2007
ER -
TY - JOUR
AU - Guerillon, C.
AU - Bigot, N.
AU - Pedeux, R.
PY - 2014
DA - 2014//
TI - The ING tumor suppressor genes: status in human tumors
JO - Cancer Lett
VL - 345
UR - https://doi.org/10.1016/j.canlet.2013.11.016
DO - 10.1016/j.canlet.2013.11.016
ID - Guerillon2014
ER -
TY - JOUR
AU - Ashshi, A. M.
AU - El-Shemi, A. G.
AU - Dmitriev, I. P.
AU - Kashentseva, E. A.
AU - Curiel, D. T.
PY - 2016
DA - 2016//
TI - Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer
JO - J Ovarian Res
VL - 9
UR - https://doi.org/10.1186/s13048-016-0248-5
DO - 10.1186/s13048-016-0248-5
ID - Ashshi2016
ER -
TY - JOUR
AU - Krasnykh, V.
AU - Belousova, N.
AU - Korokhov, N.
AU - Mikheeva, G.
AU - Curiel, D. T.
PY - 2001
DA - 2001//
TI - Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin
JO - J Virol
VL - 75
UR - https://doi.org/10.1128/JVI.75.9.4176-4183.2001
DO - 10.1128/JVI.75.9.4176-4183.2001
ID - Krasnykh2001
ER -
TY - JOUR
AU - Maizel, J. V.
AU - White, D. O.
AU - Scharff, M. D.
PY - 1968
DA - 1968//
TI - The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
JO - Virology
VL - 36
UR - https://doi.org/10.1016/0042-6822(68)90121-9
DO - 10.1016/0042-6822(68)90121-9
ID - Maizel1968
ER -
TY - JOUR
AU - Mittereder, N.
AU - March, K. L.
AU - Trapnell, B. C.
PY - 1996
DA - 1996//
TI - Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
JO - J Virol
VL - 70
ID - Mittereder1996
ER -
TY - JOUR
AU - Euhus, D. M.
AU - Hudd, C.
AU - LaRegina, M. C.
AU - Johnson, F. E.
PY - 1986
DA - 1986//
TI - Tumor measurement in the nude mouse
JO - J Surg Oncol
VL - 31
UR - https://doi.org/10.1002/jso.2930310402
DO - 10.1002/jso.2930310402
ID - Euhus1986
ER -
TY - JOUR
AU - Tomayko, M. M.
AU - Reynolds, C. P.
PY - 1989
DA - 1989//
TI - Determination of subcutaneous tumor size in athymic (nude) mice
JO - Cancer Chemother Pharmacol
VL - 24
UR - https://doi.org/10.1007/BF00300234
DO - 10.1007/BF00300234
ID - Tomayko1989
ER -
TY - JOUR
AU - Arap, W.
AU - Pasqualini, R.
AU - Ruoslahti, E.
PY - 1998
DA - 1998//
TI - Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
JO - Science
VL - 279
UR - https://doi.org/10.1126/science.279.5349.377
DO - 10.1126/science.279.5349.377
ID - Arap1998
ER -
TY - JOUR
AU - Pasqualini, R.
AU - Koivunen, E.
AU - Ruoslahti, E.
PY - 1997
DA - 1997//
TI - Alpha v integrins as receptors for tumor targeting by circulating ligands
JO - Nat Biotechnol
VL - 15
UR - https://doi.org/10.1038/nbt0697-542
DO - 10.1038/nbt0697-542
ID - Pasqualini1997
ER -
TY - JOUR
AU - McCloskey, C.
AU - Rodriguez, G.
AU - Galpin, K.
AU - Vanderhyden, B.
PY - 2018
DA - 2018//
TI - Ovarian cancer immunotherapy: preclinical models and emerging therapeutics
JO - Cancers
VL - 10
UR - https://doi.org/10.3390/cancers10080244
DO - 10.3390/cancers10080244
ID - McCloskey2018
ER -
TY - JOUR
AU - Janeway, C. A.
AU - Medzhitov, R.
PY - 2002
DA - 2002//
TI - Innate immune recognition
JO - Annu Rev Immunol
VL - 20
UR - https://doi.org/10.1146/annurev.immunol.20.083001.084359
DO - 10.1146/annurev.immunol.20.083001.084359
ID - Janeway2002
ER -
TY - JOUR
AU - Zhou, F.
PY - 2009
DA - 2009//
TI - Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation
JO - Int Rev Immunol
VL - 28
UR - https://doi.org/10.1080/08830180902978120
DO - 10.1080/08830180902978120
ID - Zhou2009
ER -
TY - JOUR
AU - Kawai, T.
AU - Akira, S.
PY - 2010
DA - 2010//
TI - The role of pattern-recognition receptors in innate immunity: update on toll-like receptors
JO - Nat Immunol
VL - 11
UR - https://doi.org/10.1038/ni.1863
DO - 10.1038/ni.1863
ID - Kawai2010
ER -
TY - JOUR
AU - Neefjes, J.
AU - Jongsma, M. L.
AU - Paul, P.
AU - Bakke, O.
PY - 2011
DA - 2011//
TI - Towards a systems understanding of MHC class I and MHC class II antigen presentation
JO - Nat Rev Immunol
VL - 11
UR - https://doi.org/10.1038/nri3084
DO - 10.1038/nri3084
ID - Neefjes2011
ER -
TY - JOUR
AU - Li, Y.
AU - Wang, L. X.
AU - Yang, G.
AU - Hao, F.
AU - Urba, W. J.
AU - Hu, H. M.
PY - 2008
DA - 2008//
TI - Efficient cross-presentation depends on autophagy in tumor cells
JO - Cancer Res
VL - 68
UR - https://doi.org/10.1158/0008-5472.CAN-08-0161
DO - 10.1158/0008-5472.CAN-08-0161
ID - Li2008
ER -
TY - JOUR
AU - Kim, K. H.
AU - Ryan, M. J.
AU - Estep, J. E.
AU - Miniard, B. M.
AU - Rudge, T. L.
AU - Peggins, J. O.
PY - 2011
DA - 2011//
TI - A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Delta24 in advance of a phase I clinical trial in ovarian cancer patients
JO - Hum Gene Ther
VL - 22
UR - https://doi.org/10.1089/hum.2010.180
DO - 10.1089/hum.2010.180
ID - Kim2011
ER -